End-of-life palliative chemotherapy: Where do we stand?

Conclusion In our center; at the end of life, there is a gradual increase in the number of patients receiving chemotherapy which significantly increased cancer patients’ odds without clear predictive factors associated with its use, which calls into question the benefits of PCT in terminally ill cancer patients.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research